Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1986-10-03
1987-11-03
Hollrah, Glennon H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
2605011, 564381, C07C 8728, A61K 31135
Patent
active
047044071
ABSTRACT:
Hydroxyalkanoic or alkandioic acid salts of dobutamine having desirable water solubility, useful in preparing intravenous solution for treatment of cardiogenic shock.
REFERENCES:
patent: 2276619 (1942-03-01), Kulz
patent: 2949359 (1960-08-01), Blout et al.
patent: 3139441 (1964-06-01), Biel
patent: 3410944 (1968-11-01), Claassen et al.
patent: 3485873 (1969-12-01), Aceto et al.
patent: 3502723 (1970-03-01), Miller et al.
patent: 3539613 (1970-11-01), Galvin et al.
patent: 3547999 (1970-12-01), Shulgin
patent: 3700692 (1972-10-01), Suh
patent: 3932461 (1976-01-01), Suh
patent: 3987200 (1976-10-01), Tuttle et al.
Ariens, Proc. Inter. Pharmacol. Meeting, 7, 247-64 (1961).
Ashbrook Charles W.
Covington Raymond
Eli Lilly and Company
Hollrah Glennon H.
Whitaker Leroy
LandOfFree
Soluble dobutamine salts does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Soluble dobutamine salts, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Soluble dobutamine salts will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1674575